| Document Symbol | Title or description |
|---|---|
|
Provisional agenda, annotations and proposed organization of work |
|
|
Report of the Executive Director on the activities of the United Nations Office on Drugs and Crime |
|
|
Note by the Secretariat on the work of the standing open-ended working group on improving the governance and financial situation of the United Nations Office on Drugs and Crime |
|
|
Report of the Secretariat on the world situation with regard to drug abuse |
|
|
Report of the Secretariat on the world situation with regard to drug trafficking |
|
|
Note by the Secretariat on promoting coordination and alignment of decisions between the Commission on Narcotic Drugs and the Programme Coordinating Board of the Joint United Nations Programme on HIV/AIDS |
|
|
Report of the Secretariat on action taken by the subsidiary bodies of the Commission on Narcotic Drugs |
|
|
Note by the Secretariat on the scope of control of substances: proposed scheduling recommendations by the World Health Organization on new psychoactives substances and medicines |
|
|
Note by the Secretariat on the scope of control of substances under the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 |
|
|
Note by the Secretariat on the proposed annual programme implementation plan for the period 2020 |
|
|
Note by the Secretariat on the scope of control of substances: proposed scheduling recommendations by the World Health Organization on cannabis and cannabis-related substances |
|
|
Report on the meeting of the intergovernmental expert group on the international challenge posed by the non-medical use of synthetic opioids held in Vienna on 3 and 4 December 2018 |
|
|
Conference room paper - Reports by intergovernmental organizations on drug control activities |
|
|
Conference room paper submitted jointly by Germany, Peru, Thailand and UNODC, titled: "The Future of Alternative Development" |
|
|
Conference room paper submitted by the Delegation of the European Union to the United Nations (Vienna) entitled: Council Conclusions "Towards a new understanding of alternative development and related development-centred drug policy interventions - Contributing to the implementation of UNGASS 2016 and the UN Sustainable Development Goals" |
|
|
Conference room paper - Note by the Secretariat on changes in the scope of control of substances: proposed scheduling recommendations by the World Health Organization |
|
|
Conference room paper - Note by the Secretariat on inter-agency cooperation and coordination of efforts in addressing and countering the world drug problem |
|
|
Conference room paper - Report of the Secretariat on Strengthening international cooperation in combating illicit opiates originating in Afghanistan through continuous and reinforced support to the Paris Pact initiative |
|
|
Conference room paper submitted by the Islamic Republic of Pakistan on the High-level Expert Group Meeting on "Preventing Drug Abuse in Educational Settings: Fostering Regional Cooperation and Partnership" |
|
|
Conference room paper submitted by the Secretary-General entitled: "What we have learned over the last ten years: A summary of knowledge acquired and produced by the UN system on drug-related matters" |
|
|
Commission on Narcotic Drugs, Report on its sixty-second session |
|
|
Statements of financial implications in connection with the adoption of draft resolutions |
|
|
List of documents before the Commission at its sixty-second session |
The Ministerial segment website provides an overview of the preparatory process as well as contributions received by interested stakeholders in support of preparations for 2019
| Document Symbol | Title or description |
|---|---|
|
Note by the Secretariat on the substantive organization of the ministerial segment of the CND at its 62nd session, in 2019 |
|
|
Ministerial declaration on strengthening our actions at the national, regional and international levels to accelerate the implementation of our joint commitments to address and counter the world drug problem |
|
|
Conference room paper submitted by Switzerland on the views of civil society for drug policies beyond 2019 |
|
|
Background documentation for the interactive, multi-stakeholder round tables of the ministerial segment |
|
|
Financial statement on the draft ministerial declaration on strengthening our actions at the national, regional and international levels to accelerate the implementation of our joint commitments to address and counter the world drug problem |
| Document Symbol | Title or description |
|---|---|
|
Statement submitted by Dianova International |
|
|
Statement submitted by Médecins du Monde |
|
|
Statement submitted by the New Zealand Drug Foundation |
|
|
Statement submitted by Corporación Acción Técnica Social (ATS) |
|
|
Statement submitted by the Gobal Network of People Living with HIV (GNP+) |
|
|
Statement submitted by the International Association for Hospice and Palliative Care (IAHPC) |
|
|
Statement submitted by the International Drug Policy Consortium (IDPC) |
|
|
Statement submitted by México Unido Contra la Delincuencia (MUCD) |
|
|
Statement submitted by the Canadian HIV/AIDS Legal Network |
|
|
Statement submitted by the Washington Office on Latin America (WOLA) |
| Document Symbol | Title or description |
|---|---|
|
Report of the Executive Director on actions taken by Member States to implement the Political Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem |
|
|
UNODC Draft Annual Programme Implementation Plan for 2020 |
